New Era Helium, Inc. (NASDAQ:NEHC) is experiencing delays in its Pecos Slope plant project, pushing the operational timeline from Q2 2024 to Q4 2024 due to financing and negotiation challenges. The company is exploring a new venture by partnering with Sharon AI,

Choice Hotels International’s stock increased by 64% over the past five years, lagging behind the broader market’s 96% growth. Earnings per share (EPS) have been increasing at an annual rate of 9.9%, aligning closely with a 10% average annual share price rise.

Stephanie Reed resigns as non-executive director of Tamboran Resources, leaving a legacy of strategic insight and corporate progress. Reed contributed significantly to Tamboran’s milestones, including the company’s successful listing on the New York Stock Exchange. Her role extended to vital committees, enhancing

Rivian faces significant challenges in 2023, including a looming 25% tariff on key EV components sourced from South Korea and China. Delivery targets have been cut, with expectations slashed to 37,000 units by 2025 due to financial and logistical hurdles. Bernstein analysts

Baker Hughes is a stable investment choice amidst speculative “story stocks.” The company has shown impressive growth, with EPS increasing by 56% over three years. Strong performance is backed by robust operational metrics, such as steady EBIT margins and a 9.1% revenue

Institutional investors control 66% of Bank of America, significantly influencing share prices and boardroom decisions. Key institutional stakeholders like Berkshire Hathaway, The Vanguard Group, and BlackRock hold 8.9%, 8.7%, and 6.9% stakes, respectively. The top 25 shareholders combined hold 49% of the

Institutional investors control a significant 56% of First Foundation Inc. (NYSE:FFWM), heavily influencing its future trajectory and stock valuation. Eight key investors hold 53% of the company’s equity, with hedge funds possessing 28%, highlighting their strategic interest. Canyon Capital Advisors LLC alone

In March 2025, the Nasdaq-100 index dropped a significant 7.6%, but Strategy Inc. and Electronic Arts managed impressive gains. Strategy Inc. achieved a 12.9% rise by investing heavily in Bitcoin, holding $35.6 billion in reserves, and raising $711 million through preferred stock

Diabetic neuropathy affects 28% to 55% of diabetes patients, with current treatments offering limited relief and side effects. MIRA Pharmaceuticals’ Ketamir-2, an oral ketamine analog, shows promise in reducing neuropathic pain in diabetic rats. Ketamir-2 avoids psychedelic effects, is non-addictive, and effectively